Vascular endothelial growth factor-C protects heart from ischemia/reperfusion injury by inhibiting cardiomyocyte apoptosis

Molecular and Cellular Biochemistry
Xu-guang ChenYu Wan

Abstract

VEGF-C is a newly identified proangiogenic protein playing an important role in vascular disease and angiogenesis. However, its role in myocardial ischemia/reperfusion (I/R) injury remains unknown. The objective of this study was to determine the role and mechanism of VEGF-C in myocardial ischemia-reperfusion injury. Rat left ventricle myocardium was injected with recombinant human VEGF-C protein (0.1 or 1.0 µg/kg b.w.) 1 h prior to myocardial ischemia-reperfusion (I/R) injury. 24 h later, the myocardial infarction size, the number of TUNEL-positive cardiomyocytes, the levels of creatine kinase (CK), CK-MB, cardiac troponin, malondialdehyde (MDA) content, and apoptosis protein Bax expression were decreased, while Bcl2 and pAkt expression were increased in VEGF-C-treated myocardium as compared to the saline-treated I/R hearts. VEGF-C also improved the function of I/R-injured hearts. In the H2O2-induced H9c2 cardiomyocytes, which mimicked the I/R injury in vivo, VEGF-C pre-treatment decreased the LDH release and MDA content, blocked H2O2-induced apoptosis by inhibiting the pro-apoptotic protein Bax expression and its translocation to the mitochondrial membrane, and consequently attenuated H2O2-induced decrease of mitochondrial me...Continue Reading

References

May 2, 2003·The Journal of Biological Chemistry·Donna M ValksAngela Clerk
Jun 5, 2003·Nature Medicine·Napoleone FerraraJennifer LeCouter
Jun 11, 2004·Annual Review of Biochemistry·Xuejun Jiang, Xiaodong Wang
Nov 13, 2004·Circulation Research·Michael T CrowRichard N Kitsis
Jul 2, 2005·Annals of Clinical Biochemistry·Vinita MishraAlan Shenkin
May 17, 2006·Apoptosis : an International Journal on Programmed Cell Death·Young Soo LeeKi Churl Chang
Jul 4, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Terhi KärpänenKari Alitalo
May 16, 2008·The FEBS Journal·Megumi EguchiGary Sweeney
Feb 25, 2011·Cardiovascular Research·Jun-Ming TangShi-You Chen
Jan 3, 2013·The Journal of Clinical Investigation·Derek J Hausenloy, Derek M Yellon
Mar 29, 2013·European Heart Journal·Georg M FröhlichDerek J Hausenloy
Jul 17, 2013·Nature Reviews. Cardiology·Ziad TaimehRoberto Bolli
Apr 11, 2015·Journal of the American College of Cardiology·Borja IbáñezFrans Van de Werf

❮ Previous
Next ❯

Citations

Aug 16, 2019·Drug and Chemical Toxicology·Ramin RezaeeMahmoud Hashemzaei
Oct 4, 2018·Current Gene Therapy·Cen YanYing-Mei Feng
Aug 31, 2017·Bulletin of Experimental Biology and Medicine·M G KlinnikovaE L Lushnikova
Oct 9, 2020·Growth Factors·Maria Rosaria De PascaleClaudio Napoli

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis